906095-68-9Relevant articles and documents
COMPOUND FOR USE IN RETINAL DISEASES
-
Paragraph 0089-0090; 0094-0096, (2021/11/04)
Provided is an aldehyde binder, specifically, disclosed is a compound as represented by formula (II) or a pharmaceutically acceptable salt.
Benzoxazole carboxamides for treating CINV and IBS-D
-
Page/Page column 48, (2008/06/13)
Compounds of formulae I and II: are disclosed as 5-HT3 inhibitors. Those compounds that exhibit central activity are useful in treating CINV; those that inhibit peripheral receptors are useful to treat IBS-D.